Boston Partners Long/Short Research Fund (BPIRX) Stock Overview
Explore Boston Partners Long/Short Research Fund’s financial performance, market position, analyst ratings, and future outlook.
Boston Partners Long/Short Research Fund (BPIRX)
Key Financials
Key Financials
Market Cap
602M
P/E Ratio
N/A
EPS (TTM)
N/A
ROE
N/A
BPIRX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Boston Partners Long/Short Research Fund (NASDAQ: BPIRX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Boston Partners Long/Short Research Fund's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BPIRX on the NASDAQ shows an RSI of 66.76, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $14.20 for the NASDAQ listing.
Key metrics behind Boston Partners Long/Short Research Fund's NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 602M. Combined with our AI analysis, these give both institutional and retail investors a clear view of BPIRX on the NASDAQ.